Drug-eluting stents: limitations of early generation and progress with newer generation devices

Khattab, A A; Windecker, S (2010). Drug-eluting stents: limitations of early generation and progress with newer generation devices. Minerva medica, 101(1), pp. 9-23. Torino: Minerva Medica

Full text not available from this repository. (Request a copy)

The success of first generation drug-eluting stents, namely by reducing restenosis and the need of repeat revascularization procedures is hampered by some limitations affecting device safety. Intense research efforts helped to identify these shortcomings and direct research to develop newer generation drug-eluting stents with the potential to circumvent these drawbacks. This review will discuss limitations of early generation drug-eluting stents, focus on solutions provided by newer generation devices, and shed light on unresolved issues and potential future solutions.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Khattab, Ahmed Aziz and Windecker, Stephan

ISSN:

0026-4806

Publisher:

Minerva Medica

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:10

Last Modified:

06 Dec 2013 13:21

PubMed ID:

20228717

Web of Science ID:

000276887800002

URI:

https://boris.unibe.ch/id/eprint/1574 (FactScience: 203350)

Actions (login required)

Edit item Edit item
Provide Feedback